Evidence That the Accumulation of 5-hydroxytryptamine in the Liver but Not in the Brain May Cause the Hypoglycaemia Induced by 5-hydroxytryptophan
Overview
Authors
Affiliations
Experiments were undertaken to determine whether the site of the hypoglycaemic action of 5-hydroxytryptophan (5-HTP), a direct precursor of 5-hydroxytryptamine (5-HT), was in the central nervous system or in the liver. The fall in blood glucose followed the rapid increase in the amount of 5-HT both in the brain and liver after 5-HTP injection into pargyline-treated and non-treated mice. Carbidopa, an inhibitor of peripheral aromatic amino acid decarboxylase, prevented the elevation of 5-HT levels in the liver of both pargyline-treated and non-treated mice. In contrast, carbidopa did not prevent but rather enhanced the elevation of 5-HT levels in the brain of both groups of mice. Corresponding to the prevention of 5-HT elevation in the liver, the fall in blood glucose was prevented by carbidopa. These results support the idea that the accumulation of 5-HT in the liver but not in the brain causes the hypoglycaemia induced by 5-HTP.
Metabolomics Panel Associated with Cystic Fibrosis-Related Diabetes toward Biomarker Discovery.
Mujammami M, Nimer R, Al Mogren M, AlMalki R, Alabdaljabar M, Benabdelkamel H ACS Omega. 2024; 9(30):32873-32880.
PMID: 39100315 PMC: 11292812. DOI: 10.1021/acsomega.4c03626.
Maffei M Int J Mol Sci. 2020; 22(1).
PMID: 33375373 PMC: 7796270. DOI: 10.3390/ijms22010181.
Insulin sensitivity and premenstrual syndrome.
Trout K, Teff K Curr Diab Rep. 2004; 4(4):273-80.
PMID: 15265470 DOI: 10.1007/s11892-004-0079-4.
Oguri S, Motegi K, Iwakura Y, Endo Y Clin Diagn Lab Immunol. 2002; 9(6):1307-12.
PMID: 12414765 PMC: 130127. DOI: 10.1128/cdli.9.6.1307-1312.2002.
Endo Y Br J Pharmacol. 1987; 90(1):161-5.
PMID: 3493049 PMC: 1917283. DOI: 10.1111/j.1476-5381.1987.tb16836.x.